Naloxone Hydrochloride

盐酸纳洛酮

Report date: 2025/02/11 11:48:06
NME

Base Information

Drug NameNaloxone Hydrochloride
Drug Alias Name盐酸纳络酮naloxonum盐酸丙烯羟吗啡酮naloxonanaloxone +[27] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOpioid receptors antagonists
TargetsOpioid receptors
Therapy Area/IndicationsRejection of lung transplantationSolid tumoursBinge-Eating Disorder +[26] 
Global Approved IndicationsOpioid-Related DisordersDrug OverdosePoisoning
Approved Indications in ChinaOpioid-Related DisordersPoisoning
Original Approved Country/TerritoryUnited States
Original Approved Date1971/04/13
Country/TerritoryCzechiaBulgariaCanada +[17] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAdapt Pharma LtdAdamis Pharmaceuticals Corp
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of California San FranciscoSTAT Therapeutics IncZMI Management Inc +[16] 
Inactive CompaniesDana-Farber Cancer InstituteNational Center For Complementary And Integrative HealthWashington University School Of Medicine +[16] 
Active IndicationsRepression-SensitizationOpioid-Related DisordersPoisoning +[10] 
Inactive IndicationsRejection of lung transplantationSolid tumoursBinge-Eating Disorder +[16] 

Other Information

ATC CodeA06AH04V03AB15
Related LinksWikipediaDrugBankKEGG